REGENXBIO Inc. Quarterly Debt-to-equity in % from Q2 2016 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: REGENXBIO Inc. quarterly Debt-to-equity history and growth rate from Q2 2016 to Q2 2024.
REGENXBIO Inc. Debt-to-equity for the quarter ending June 30, 2024 was 70.2 %, a 14.5% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	70.2	+8.89	+14.5%	Jun 30, 2024
Q1 2024	71.2	+14.1	+24.7%	Mar 31, 2024
Q4 2023	70.7	+16.7	+30.9%	Dec 31, 2023
Q3 2023	65.5	+15.4	+30.7%	Sep 30, 2023
Q2 2023	61.3	+8.4	+15.9%	Jun 30, 2023
Q1 2023	57.1	+1.25	+2.24%	Mar 31, 2023
Q4 2022	54	-4.72	-8.04%	Dec 31, 2022
Q3 2022	50.2	-19.5	-28%	Sep 30, 2022
Q2 2022	52.9	-6.92	-11.6%	Jun 30, 2022
Q1 2022	55.9	+8.17	+17.1%	Mar 31, 2022
Q4 2021	58.7	+24.5	+71.5%	Dec 31, 2021
Q3 2021	69.6	+53.7	+336%	Sep 30, 2021
Q2 2021	59.8	+49.2	+464%	Jun 30, 2021
Q1 2021	47.7	+38.6	+424%	Mar 31, 2021
Q4 2020	34.2	+26.1	+319%	Dec 31, 2020
Q3 2020	16	+8.7	+120%	Sep 30, 2020
Q2 2020	10.6	+4.44	+72%	Jun 30, 2020
Q1 2020	9.1	+3.2	+54.2%	Mar 31, 2020
Q4 2019	8.16	+2.45	+42.9%	Dec 31, 2019
Q3 2019	7.27	+1.61	+28.4%	Sep 30, 2019
Q2 2019	6.17	-0.56	-8.32%	Jun 30, 2019
Q1 2019	5.9	-0.94	-13.7%	Mar 31, 2019
Q4 2018	5.71	-1.04	-15.4%	Dec 31, 2018
Q3 2018	5.66	-0.68	-10.7%	Sep 30, 2018
Q2 2018	6.73	+0.12	+1.82%	Jun 30, 2018
Q1 2018	6.84	+0.47	+7.37%	Mar 31, 2018
Q4 2017	6.75	+0.99	+17.2%	Dec 31, 2017
Q3 2017	6.34	+1.77	+38.8%	Sep 30, 2017
Q2 2017	6.61	+3.48	+111%	Jun 30, 2017
Q1 2017	6.37			Mar 31, 2017
Q4 2016	5.76			Dec 31, 2016
Q3 2016	4.56			Sep 30, 2016
Q2 2016	3.13			Jun 30, 2016

* An asterisk sign (*) next to the value indicates that the value is likely invalid.